Medtronic is a medical device company located in Ireland, which is part of the Healthcare sector, and is traded under the ticker MDT on the NYSE exchange.
Medtronic stock last closed at $91.75, down 0.41% from the previous day, and has decreased 3.03% in one year. It has overperformed other stocks in the Medical Devices industry by 0.96 percentage points. Medtronic stock is currently +25.14% from its 52-week low of $73.32, and -13.71% from its 52-week high of $106.33.
As of Sep 21, 2026, there are 1.28B MDT shares outstanding. The market capitalization of MDT is $117.36B. In the past 24 hours, 7.31M MDT shares were traded.
You will need a brokerage account in order to access the NYSE market and buy MDT shares.
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to invest in MDT today.
Now that you have filled out your info on stock apps to use, you need to deposit funds:
Check out the video below to see the process of depositing funds into your new brokerage account.
After you have identified the best place to buy Medtronic stock, it's critical to research their stock before you invest, so you can comprehend the risk and opportunity.
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on MDT's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MDT's intrinsic value.
Using relative valuations ratios:
You can access more valuation research on MDT's stock here.
Out of 20 sell side analysts who track MDT, the consensus analyst rating on MDT is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Rick Wise, a top 13% analyst from Stifel Nicolaus maintains MDT with a hold rating and raises their MDT price target from $80.00 to $95.00, on Sep 2, 2026.
David Rescott, a top 17% analyst from Baird maintains MDT with a hold rating and raises their MDT price target from $91.00 to $100.00, on Sep 2, 2026.
Ryan Zimmerman, a top 20% analyst from BTIG maintains MDT with a strong buy rating and raises their MDT price target from $91.00 to $100.00, on Sep 1, 2026.
BTIG's Ryan Zimmerman raised their price target on Medtronic (NYSE: MDT) by 9.9% from $91 to $100 on 2026/09/01. The analyst maintained their Strong Buy rating on the stock.
Medtronic reported its Q1 2027 earnings.
Raising their price target, Zimmerman headlined that the news regarding the company's investment in privately-held, Hong Kong-basedCornerstone Robotics will raise questions about Hugo's durability.
Their view, however, the analyst said, is that Medtronic's multi-option approach was inevitable.
Management's raised FY 2027 guidance looks conservative, Zimmerman opined, because it only accounts for a portion of the Q1 2027 beat, with the remainder reinvested into commercial acceleration and M&A, which leaves room for further upside from here.
For Q1 2027, Medtronic PLC reported:
For FY 2027, management guided:
Chairman & CEO Geoff Martha commented: “Our performance reflects the strongest annual top-line growth Medtronic has delivered in 10 years, powered by disciplined execution across our portfolio and continued operational rigor.
"These results represent the compounding impact of deliberate choices we’ve made to strengthen our strategy, sharpen execution, and invest in the areas that will drive our future.
"We saw continued strength in some of our largest businesses like CRM, CST and Surgical, and we are building momentum in our highest growth opportunities, such as Affera, Symplicity, Hugo, Altaviva and Stealth AXiS.
"Together with the investments we’re making in our pipeline, Medtronic is well positioned to deliver sustained growth and long-term value.”
Mike Matson, a top 17% analyst from Needham reiterates MDT with a buy rating and maintains their MDT price target from $114.00 to $114.00, on Sep 1, 2026.
Joshua Jennings, a top 22% analyst from TD Cowen maintains MDT with a strong buy rating and raises their MDT price target from $100.00 to $110.00, on Aug 28, 2026.
You can dig deeper into what analysts are saying on the Medtronic stock forecast page.
Last year, MDT earnings were $5.23B. During the last five year, MDT's earnings have grown by 7.27% per year. This was slower than the Medical Devices industry average of 12.16%.
Last year, MDT revenue was $37.54B. During the last 5 year, MDT's revenue has gone up by 3.51% per year. This was slower than the Medical Devices industry average of 8.68%.
You can research MDT's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at MDT have sold more shares than they have bought.
Harry Skip Kiil, Pres;EVP of MDT, was the latest MDT insider to sell. They sold $138,882.95 worth of MDT stock on Sep 16, 2026.
Research more about who owns MDT stock here.
Medtronic pays a dividend of 1.56%, compared to the Medical Devices industry's average dividend yield of 1.78%. If you owned $1,000 worth of MDT stock, you would have received $15.59 last year.
Medtronic dividend payments have consistently grown over the past decade and have remained stable.
Find more analysis about Medtronic dividend yield and history here.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary order types:
Click the Open button and eToro will execute your order.
If you require additional help with buying stocks on eToro, watch the helpful video below:
Now that you own some MDT stock, you'll want to stay up-to-date on your company.
Put MDT on a watchlist to track the latest developments regarding your MDT stock.
To summarize, here are the 6 steps for buying Medtronic stock:
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to track your new investment in Medtronic, create a watchlist today.